Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
8 "Fracture"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Incidence of and Factors for Self-reported Fragility Fractures Among Middle-aged and Elderly Women in Rural Korea: An 11-Year Follow-up Study
Soon-Ki Ahn, Sin Kam, Byung-Yeol Chun
J Prev Med Public Health. 2014;47(6):289-297.   Published online October 2, 2014
DOI: https://doi.org/10.3961/jpmph.14.020
  • 13,778 View
  • 98 Download
  • 1 Crossref
AbstractAbstract PDF
Objectives
This community-based cohort study was performed to investigate the incidence of and factors related to self-reported fragility fractures among middle-aged and elderly women living in rural Korea.
Methods
The osteoporosis cohort recruited 430 women 40 to 69 years old in 1999, and 396 of these women were followed over 11 years. In 1999, questionnaires from all participants assessed general characteristics, medical history, lifestyle, menstrual and reproductive characteristics, and bone mineral density. In 2010, self-reported fractures and the date, site, and cause of these fractures were recorded. Cox proportional hazards models were used to calculate hazard ratios (HRs).
Results
Seventy-six participants among 3949.7 person-years experienced fragility fractures during the 11-year follow-up. The incidence of fragility fractures was 1924.2 per 100 000 person-years (95% confidence interval [CI], 1491.6 to 2356.8). In the multivariate model, low body mass index (HR, 2.66; 95% CI, 1.13 to 6.24), a parental history of osteoporosis (HR, 2.03; 95% CI, 1.18 to 3.49), and postmenopausal status (HR, 3.50; 95% CI, 1.05 to 11.67) were significantly related to fragility fracture.
Conclusions
Fracture prevention programs are needed among postmenopausal, rural, Korean women with a low body mass index and parental history of osteoporosis Korea.
Summary

Citations

Citations to this article as recorded by  
  • Comparison of intraoperative radiation exposure with and without use of distal targeting device: a randomized control study
    Jun-Il Yoo, Hojin Jeong, Jaeboem Na, Sang-Youn Song, Jung-Taek Kim, Yong-Han Cha, Chan Ho Park
    Archives of Orthopaedic and Trauma Surgery.2019; 139(11): 1579.     CrossRef
Levothyroxine Dose and Fracture Risk According to the Osteoporosis Status in Elderly Women
Young-Jin Ko, Ji Young Kim, Joongyub Lee, Hong-Ji Song, Ju-Young Kim, Nam-Kyong Choi, Byung-Joo Park
J Prev Med Public Health. 2014;47(1):36-46.   Published online January 29, 2014
DOI: https://doi.org/10.3961/jpmph.2014.47.1.36
  • 12,934 View
  • 174 Download
  • 28 Crossref
AbstractAbstract PDF
Objectives

To evaluate the association between fracture risk and levothyroxine use in elderly women with hypothyroidism, according to previous osteoporosis history.

Methods

We conducted a cohort study from the Korean Health Insurance Review and Assessment Service claims database from January 2005 to June 2006. The study population comprised women aged ≥65 years who had been diagnosed with hypothyroidism and prescribed levothyroxine monotherapy. We excluded patients who met any of the following criteria: previous fracture history, hyperthyroidism, thyroid cancer, or pituitary disorder; low levothyroxine adherence; or a follow-up period <90 days. We categorized the daily levothyroxine doses into 4 groups: ≤50 µg/d, 51 to 100 µg/d, 101 to 150 µg/d, and >150 µg/d. The hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with the Cox proportional hazard model, and subgroup analyses were performed according to the osteoporosis history and osteoporosis-specific drug prescription status.

Results

Among 11 155 cohort participants, 35.6% had previous histories of osteoporosis. The adjusted HR of fracture for the >150 µg/d group, compared with the 51 to 100 µg/d group, was 1.56 (95% CI, 1.03 to 2.37) in osteoporosis subgroup. In the highly probable osteoporosis subgroup, restricted to patients who were concurrently prescribed osteoporosis-specific drugs, the adjusted HR of fracture for the >150 µg/d group, compared with the 51 to 100 µg/d group, was 1.93 (95% CI, 1.14 to 3.26).

Conclusions

While further studies are needed, physicians should be concerned about potential levothyroxine overtreatment in elderly osteoporosis patients.

Summary

Citations

Citations to this article as recorded by  
  • Diagnosis and therapeutic approach to bone health in patients with hypopituitarism
    Justyna Kuliczkowska-Płaksej, Aleksandra Zdrojowy-Wełna, Aleksandra Jawiarczyk-Przybyłowska, Łukasz Gojny, Marek Bolanowski
    Reviews in Endocrine and Metabolic Disorders.2024; 25(3): 513.     CrossRef
  • Hypopituitarism and bone disease: pathophysiology, diagnosis and treatment outcomes
    Amit Akirov, Yaron Rudman, Maria Fleseriu
    Pituitary.2024;[Epub]     CrossRef
  • Diversity of the diet is correlated with osteoporosis in post-menopausal women: an Iranian case-control study
    Behnood Abbasi, Mohammad Mahdi Hajinasab, Zahra Mohammadi Zadeh, Paniz Ahmadi
    Frontiers in Public Health.2024;[Epub]     CrossRef
  • Impact of Patient Age on Management of Hypothyroidism: A Survey of Physicians from Three Developing Regions
    Salem A. Beshyah, Mohammed Bashir, Khadija Hafidh, Bachar Afandi, Shehla Shaikh, Sonia Hammami, Ali B. Khalil
    Journal of Diabetes and Endocrine Practice.2024; 07(03): 135.     CrossRef
  • Association Between Periodontal Diseases and Hypothyroidism: A Case–Control Study
    Fatemah AlAhmari, Hind Albahouth, Hadeel Almalky, Ebtihal Almutairi, Muzun Alatyan, Lama Alotaibi
    International Journal of General Medicine.2024; Volume 17: 3613.     CrossRef
  • Refractory hypothyroidism in children: an overview
    Kotb Abbass Metwalley, Hekma Saad Farghaly
    Journal of Pediatric Endocrinology and Metabolism.2024; 37(10): 841.     CrossRef
  • Evaluation and Management of Bone Health in Patients with Thyroid Diseases: A Position Statement of the Korean Thyroid Association
    A Ram Hong, Ho-Cheol Kang
    Endocrinology and Metabolism.2023; 38(2): 175.     CrossRef
  • Refractory Hypothyroidism: Unraveling the Complexities of Diagnosis and Management
    Juan Eduardo Quiroz-Aldave, Marcio José Concepción-Zavaleta, María del Carmen Durand-Vásquez, Luis Alberto Concepción-Urteaga, Elman Rolando Gamarra-Osorio, Jacsel Suárez-Rojas, Luciana del Pilar Rafael-Robles, José Paz-Ibarra, Alejandro Román-González
    Endocrine Practice.2023; 29(12): 1007.     CrossRef
  • Assessing the cardiovascular effects of levothyroxine use in an ageing United Kingdom population (ACEL-UK) protocol: a cohort and target trial emulation study
    Mia Holley, Salman Razvi, Rosie Dew, Ian Maxwell, Scott Wilkes
    Thyroid Research.2023;[Epub]     CrossRef
  • Understanding Worry About Risks Associated With Thyroid Hormone Therapy: A National Survey of Endocrinologists, Family Physicians, and Geriatricians
    Kimi Shah, David Reyes-Gastelum, Brittany L. Gay, Maria Papaleontiou
    Endocrine Practice.2022; 28(1): 25.     CrossRef
  • Evaluation and Management of Bone Health in Patients with Thyroid Diseases: a Position Statement from the Korean Thyroid Association
    A Ram Hong, Hwa Young Ahn, Bu Kyung Kim, Seong Hee Ahn, So Young Park, Min-Hee Kim, Jeongmin Lee, Sun Wook Cho, Ho-Cheol Kang
    International Journal of Thyroidology.2022; 15(1): 1.     CrossRef
  • Levothyroxine Therapy in Elderly Patients With Hypothyroidism
    Grigoris Effraimidis, Torquil Watt, Ulla Feldt-Rasmussen
    Frontiers in Endocrinology.2021;[Epub]     CrossRef
  • Systemic medicines taken by adult special care dental patients and implications for the management of their care
    Nicholas Ransford, Ben Marnell, Christine Randall, Clare Yates, Gillian Howie
    British Dental Journal.2021; 231(1): 33.     CrossRef
  • The Influence of Thyroid Pathology on Osteoporosis and Fracture Risk: A Review
    Dragos Apostu, Ondine Lucaciu, Daniel Oltean-Dan, Alexandru-Dorin Mureșan, Cristina Moisescu-Pop, Andrei Maxim, Horea Benea
    Diagnostics.2020; 10(3): 149.     CrossRef
  • Comparison of the efficacy between once-monthly oral ibandronate and risedronate among Korean women with osteoporosis: a nationwide population-based study
    Dong Ryul Lee, Jungun Lee
    Osteoporosis International.2019; 30(3): 659.     CrossRef
  • The effect of thyroid functions on osteopenia of prematurity in preterm infants
    Ufuk Çakır, Cuneyt Tayman
    Journal of Pediatric Endocrinology and Metabolism.2019; 32(1): 65.     CrossRef
  • Understanding hypothyroidism in Unani medicine
    Md. Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Barkati Md. Tarique
    Journal of Integrative Medicine.2019; 17(6): 387.     CrossRef
  • Team Approach: Multidisciplinary Treatment of Hip Fractures in Elderly Patients
    Wender Figved, Marius Myrstad, Ingvild Saltvedt, Merete Finjarn, Liv Marie Flaten Odland, Frede Frihagen
    JBJS Reviews.2019; 7(6): e6.     CrossRef
  • Effect of sodium levothyroxine on histomorphometry, histopathology, histochemistry, and immunohistochemistry of articular cartilage in female mice
    Simin Fazelipour, Minoo Shafii, Mahsa Hadipour Jahromi, Zahra Tootian, Mohammad Taghi Sheibani, Hassan Morovvati, Marzieh Minaei, Anahita Shahriari, Pooneh Koochaki, Safora Karimi
    Comparative Clinical Pathology.2018; 27(1): 45.     CrossRef
  • High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone–Suppressive Therapy for Thyroid Carcinoma
    Gherardo Mazziotti, Anna Maria Formenti, Stefano Frara, Roberto Olivetti, Giuseppe Banfi, Maurizio Memo, Roberto Maroldi, Raffaele Giubbini, Andrea Giustina
    The Journal of Clinical Endocrinology & Metabolism.2018; 103(3): 956.     CrossRef
  • Subclinical thyrotoxicosis and bone
    M. Doga, A.M. Formenti, S. Frara, M. Memo, A. Giustina, G. Mazziotti
    Current Opinion in Endocrine and Metabolic Researc.2018;[Epub]     CrossRef
  • Effects of Abnormal Thyroid Function Status to Bone Metabolism
    Hwa Young Ahn
    International Journal of Thyroidology.2018; 11(1): 21.     CrossRef
  • RETRACTED ARTICLE: The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies
    Ruifei Yang, Liang Yao, Yuan Fang, Jing Sun, Tiankang Guo, Kehu Yang, Limin Tian
    Journal of Bone and Mineral Metabolism.2018; 36(2): 209.     CrossRef
  • MANAGEMENT OF ENDOCRINE DISEASE: l-Thyroxine replacement therapy in the frail elderly: a challenge in clinical practice
    R M Ruggeri, F Trimarchi, B Biondi
    European Journal of Endocrinology.2017; 177(4): R199.     CrossRef
  • THE IMPACT OF AGE IN THE MANAGEMENT OF HYPOTHYROIDISM: RESULTS OF A NATIONWIDE SURVEY
    Maria Papaleontiou, Brittany L. Gay, Nazanene H. Esfandiari, Sarah T. Hawley, Megan R. Haymart
    Endocrine Practice.2016; 22(6): 708.     CrossRef
  • TSH Suppression after Differentiated Thyroid Cancer Surgery and Osteoporosis
    Kyoung Sik Park
    Korean Journal of Endocrine Surgery.2016; 16(1): 1.     CrossRef
  • TSH Suppression after Differentiated Thyroid Cancer Surgery and Osteoporosis
    Kyoung Sik Park
    Korean Journal of Endocrine Surgery.2016; 16(1): 1.     CrossRef
  • Role of Thyroid Hormones in Skeletal Development and Bone Maintenance
    J. H. Duncan Bassett, Graham R. Williams
    Endocrine Reviews.2016; 37(2): 135.     CrossRef
Zolpidem Use and Risk of Fracture in Elderly Insomnia Patients
Dong-Yoon Kang, Soyoung Park, Chul-Woo Rhee, Ye-Jee Kim, Nam-Kyong Choi, Joongyub Lee, Byung-Joo Park
J Prev Med Public Health. 2012;45(4):219-226.   Published online July 31, 2012
DOI: https://doi.org/10.3961/jpmph.2012.45.4.219
  • 17,772 View
  • 176 Download
  • 80 Crossref
AbstractAbstract PDF
Objectives

To evaluate the risk of fractures related with zolpidem in elderly insomnia patients.

Methods

Health claims data on the entire South Korean elderly population from January 2005 to June 2006 were extracted from the Health Insurance Review and Assessment Service database. We applied a case-crossover design. Cases were defined as insomnia patients who had a fracture diagnosis. We set the hazard period of 1 day length prior to the fracture date and four control periods of the same length at 5, 10, 15, and 20 weeks prior to the fracture date. Time independent confounding factors such as age, gender, lifestyle, cognitive function level, mobility, socioeconomic status, residential environment, and comorbidity could be controlled using the casecrossover design. Time dependent confounding factors, especially co-medication of patients during the study period, were adjusted by conditional logistic regression analysis. The odds ratios and their 95% confidence intervals (CIs) were estimated for the risk of fracture related to zolpidem.

Results

One thousand five hundred and eight cases of fracture were detected in insomnia patients during the study period. In our data, the use of zolpidem increased the risk of fracture significantly (adjusted odds ratio [aOR], 1.72; 95% CI, 1.37 to 2.16). However, the association between benzodiazepine hypnotics and the risk of fracture was not statistically significant (aOR, 1.00; 95% CI, 0.83 to 1.21). Likewise, the results were not statistically significant in stratified analysis with each benzodiazepine generic subgroup.

Conclusions

Zolpidem could increase the risk of fracture in elderly insomnia patients. Therefore zolpidem should be prescribed carefully and the elderly should be provided with sufficient patient education.

Summary

Citations

Citations to this article as recorded by  
  • Sedative-hypnotics and osteoporotic fractures: A systematic review of observational studies with over six million individuals
    Chong Xu, Janice Ching Nam Leung, Jiaying Shi, Dawn Hei Lum, Francisco Tsz Tsun Lai
    Sleep Medicine Reviews.2024; 73: 101866.     CrossRef
  • Burden of narcolepsy in Japan: A health claims database study evaluating direct medical costs and comorbidities
    Yuta Kamada, Aya Imanishi, Shih-Wei Chiu, Takuhiro Yamaguchi
    Sleep Medicine.2024; 114: 119.     CrossRef
  • Analysis of Drugs Prescribed to Elderly Patients in a Tertiary Health Care Center in Raipur, Central India: An Observational Study
    Yogendra Keche, Nitin R Gaikwad, Preetam N Wasnik, Keshao Nagpure, Md Sabah Siddiqui, Apoorva Joshi, Suryaprakash Dhaneria, Gevesh Dewangan, Jhasaketan Meher, Pranita Das
    Cureus.2024;[Epub]     CrossRef
  • Professionals' treatment goals for long-term benzodiazepine and Z-drugs management: a qualitative study
    Pauline Van Ngoc, Melissa Ceuterick, Jean-Luc Belche, Beatrice Scholtes
    BJGP Open.2024; 8(1): BJGPO.2023.0034.     CrossRef
  • Nurses' attitudes, beliefs and knowledge of sleep health in residential aged care: An integrative literature review
    Christopher J. Gordon, Tracee Fernandez, Emily Chen, Mariam Basheti, Matthew Rahimi, Bandana Saini
    Journal of Advanced Nursing.2024;[Epub]     CrossRef
  • Reasons and impacts of hypnotic overuse in seniors
    Petra Höferová, Eva Aigelová
    Psychiatrie pro praxi.2024; 25(3): E1.     CrossRef
  • Comparative risk of fracture in community‐dwelling older adults initiating suvorexant versus Z‐drugs: Results from LIFE study
    Motohiko Adomi, Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
    Journal of the American Geriatrics Society.2023; 71(1): 109.     CrossRef
  • Analysis of the prescription trends of potentially inappropriate medications in Korean older outpatients by sex: A retrospective study using data from the health insurance review and assessment service
    Jae-Yong Dong, Jin-Han Ju, Young-Mo Yang
    Medicine.2023; 102(34): e34818.     CrossRef
  • Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study
    Ryozo Yoshioka, Seiichiro Yamamoto, Eiji Nakatani, Norio Yasui-Furukori
    PLOS ONE.2023; 18(4): e0284726.     CrossRef
  • The epidemiology of new persistent hypnotic/sedative use after surgical procedures: a retrospective cohort study
    D. H. Magnusson, T. I. Albertsson, F. Jonsdottir, M. I. Sigurdsson
    Anaesthesia.2023; 78(8): 995.     CrossRef
  • Zolpidem as a high risk factor for elderly suicide in South Korea
    Eun Kim, Jae Hee Lee, Duk Hee Lee
    Archives of Suicide Research.2022; 26(2): 831.     CrossRef
  • Reducing Sedative-Hypnotics Among Hospitalized Patients: a Multi-centered Study
    Christine Soong, Cheryl Ethier, Yuna Lee, Dalia Othman, Lisa Burry, Peter E. Wu, Karen A. Ng, John Matelski, Barbara Liu
    Journal of General Internal Medicine.2022; 37(10): 2345.     CrossRef
  • Very long-term outcome of cognitive behavioral therapy for insomnia: one- and ten-year follow-up of a randomized controlled trial
    Susanna Jernelöv, Kerstin Blom, Nils Hentati Isacsson, Pontus Bjurner, Ann Rosén, Martin Kraepelien, Erik Forsell, Viktor Kaldo
    Cognitive Behaviour Therapy.2022; 51(1): 72.     CrossRef
  • Efficacy and safety of Z-substances in the management of insomnia in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing
    Vincenz Scharner, Lukas Hasieber, Andreas Sönnichsen, Eva Mann
    BMC Geriatrics.2022;[Epub]     CrossRef
  • Insomnia Diagnosis, Prescribed Hypnotic Medication Use, and Risk for Serious Fall Injuries in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study
    S Justin Thomas, Swati Sakhuja, Lisandro D Colantonio, Mei Li, Paul Muntner, Kristi Reynolds, C Barrett Bowling
    Sleep.2022;[Epub]     CrossRef
  • Potentially Inappropriate Medication Use in Patients with Dementia
    Kyungwon Yoon, Jung-Tae Kim, Won-Gun Kwack, Donghyun Kim, Kyung-Tae Lee, Seungwon Yang, Sangmin Lee, Yeo-Jin Choi, Eun-Kyoung Chung
    International Journal of Environmental Research and Public Health.2022; 19(18): 11426.     CrossRef
  • Z-drugs and falls in nursing home patients: data from the INCUR study
    Sarah Damanti, Moreno Tresoldi, Philipe de Souto Barreto, Yves Rolland, Matteo Cesari
    Aging Clinical and Experimental Research.2022; 34(12): 3145.     CrossRef
  • Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial
    Ingo Fietze, Claudio L. A. Bassetti, David W. Mayleben, Scott Pain, Dalma Seboek Kinter, William V. McCall
    Drugs & Aging.2022; 39(10): 795.     CrossRef
  • Reacciones adversas medicamentosas de los hipnóticos más utilizados en España
    A.J. Pardo-Cabello, V. Manzano-Gamero, J.D. Luna-del Castillo
    Revista Clínica Española.2021; 221(2): 128.     CrossRef
  • Adverse drug reactions among the most used hypnotic drugs in Spain
    A.J. Pardo-Cabello, V. Manzano-Gamero, J.D. Luna-Del Castillo
    Revista Clínica Española (English Edition).2021; 221(2): 128.     CrossRef
  • Non-benzodiazepine hypnotic use for sleep disturbance in people aged over 55 years living with dementia: a series of cohort studies
    Kathryn Richardson, George M Savva, Penelope J Boyd, Clare Aldus, Ian Maidment, Eduwin Pakpahan, Yoon K Loke, Antony Arthur, Nicholas Steel, Clive Ballard, Robert Howard, Chris Fox
    Health Technology Assessment.2021; 25(1): 1.     CrossRef
  • Sleep Disturbance, Sleep Disorders and Co-Morbidities in the Care of the Older Person
    Christine E. Mc Carthy
    Medical Sciences.2021; 9(2): 31.     CrossRef
  • Effectiveness of App-Based Yoga of Immortals (YOI) Intervention for Insomnia in Asian Population during Pandemic Restrictions
    Renuka Tunuguntla, Hari Siva Gurunadha Rao Tunuguntla, Himanshu Kathuria, Sadhna Verma
    International Journal of Environmental Research and Public Health.2021; 18(11): 5706.     CrossRef
  • Effects of anticholinergic and sedative medication use on fractures: A self‐controlled design study
    Shahar Shmuel, Virginia Pate, Marc J. Pepin, Janine C. Bailey, Yvonne M. Golightly, Laura C. Hanson, Til Stürmer, Rebecca B. Naumann, Danijela Gnjidic, Jennifer L. Lund
    Journal of the American Geriatrics Society.2021; 69(11): 3212.     CrossRef
  • Effect of Multimorbidity on Fragility Fractures in Community-Dwelling Older Adults: Shimane CoHRE Study
    Garu A, Shozo Yano, Abdullah Md Sheik, Aorigele Yu, Kenta Okuyama, Miwako Takeda, Kunie Kohno, Masayuki Yamasaki, Minoru Isomura, Toru Nabika, Atsushi Nagai
    Journal of Clinical Medicine.2021; 10(15): 3225.     CrossRef
  • Clinical consequences of abuse and misuse of hypnotics and analgesics in geriatric population
    Paulina Trawka, Jakub Husejko, Kornelia Kędziora-Kornatowska
    BÓL.2021; 22(2): 1.     CrossRef
  • Exploring the Mechanisms Underlying Drug-Induced Fractures Using the Japanese Adverse Drug Event Reporting Database
    Shinya Toriumi, Akinobu Kobayashi, Hitoshi Sueki, Munehiro Yamamoto, Yoshihiro Uesawa
    Pharmaceuticals.2021; 14(12): 1299.     CrossRef
  • Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review
    Judith Sys, Simon Van Cleynenbreugel, Mieke Deschodt, Lorenz Van der Linden, Jos Tournoy
    European Journal of Clinical Pharmacology.2020; 76(3): 363.     CrossRef
  • Association between benzodiazepines use and risk of hip fracture in the elderly people: A meta-analysis of observational studies
    Tahmina Nasrin Poly, Md. Mohaimenul Islam, Hsuan-Chia Yang, Yu-Chuan (Jack) Li
    Joint Bone Spine.2020; 87(3): 241.     CrossRef
  • Association entre prise de benzodiazépines et risque de fracture de la hanche chez la personne âgée : méta-analyse d’études observationnelles
    Tahmina Nasrin Poly, Md. Mohaimenul Islam, Hsuan-Chia Yang, Yu-Chuan (Jack) Li
    Revue du Rhumatisme.2020; 87(3): 210.     CrossRef
  • Acute cognitive effects of the hypocretin receptor antagonist almorexant relative to zolpidem and placebo: a randomized clinical trial
    Thomas C Neylan, Anne Richards, Thomas J Metzler, Leslie M Ruoff, Jonathan Varbel, Aoife O’Donovan, Melinda Sivasubramanian, Terri Motraghi, Jennifer Hlavin, Steven L Batki, Sabra S Inslicht, Kristin Samuelson, Stephen R Morairty, Thomas S Kilduff
    Sleep.2020;[Epub]     CrossRef
  • More than a quarter century of the most prescribed sleeping pill: Systematic review of zolpidem use by older adults
    Flávio V. Machado, Luciana L. Louzada, Nathan E. Cross, Einstein F. Camargos, Thien Thanh Dang-Vu, Otávio T. Nóbrega
    Experimental Gerontology.2020; 136: 110962.     CrossRef
  • Association of Hypnotic Drug Use with Fall Incidents in Hospitalized Elderly Patients: A Case-Crossover Study
    Haruki Torii, Motozumi Ando, Hideaki Tomita, Tomoko Kobaru, Mahoko Tanaka, Kazuhide Fujimoto, Rumiko Shimizu, Hiroaki Ikesue, Satoshi Okusada, Tohru Hashida, Noriaki Kume
    Biological and Pharmaceutical Bulletin.2020; 43(6): 925.     CrossRef
  • Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer’s Disease
    Shanna L. Burke, Tianyan Hu, Christine E. Spadola, Aaron Burgess, Tan Li, Tamara Cadet
    Journal of Aging and Health.2019; 31(2): 322.     CrossRef
  • Twelve-year trend in the use of zolpidem and physicians’ non-compliance with recommended duration: a Korean national health insurance database study
    Yunjeung Jang, Inmyung Song, In-Sun Oh, Ju-Young Shin
    European Journal of Clinical Pharmacology.2019; 75(1): 109.     CrossRef
  • Association between Elimination Half-life of Benzodiazepines and Falls in the Elderly: A Meta-analysis of Observational Studies
    Chikako Masudo, Yukari Ogawa, Naomi Yamashita, Kiyoshi Mihara
    YAKUGAKU ZASSHI.2019; 139(1): 113.     CrossRef
  • Effectiveness and safety of fire-needle moxibustion on insomnia
    Cuiling Liu, Zhiqiang Chen, Ting Li, Zhihua Yang, Qingsong Zhang, Jianping Yin, Peng Zhou, Wei Fu, BaiShu Chen
    Medicine.2019; 98(7): e14509.     CrossRef
  • Treatment of sleep disturbance in older adults
    Amy C. Reynolds, Robert J. Adams
    Journal of Pharmacy Practice and Research.2019; 49(3): 296.     CrossRef
  • An Implementation Guide to Promote Sleep and Reduce Sedative-Hypnotic Initiation for Noncritically Ill Inpatients
    Christine Soong, Lisa Burry, Hyung J. Cho, Evelyn Gathecha, Flora Kisuule, Cara Tannenbaum, Abi Vijenthira, Timothy Morgenthaler
    JAMA Internal Medicine.2019; 179(7): 965.     CrossRef
  • Evaluation of Dissolution Profile between Original and Generic Products of Zolpidem Tartrate by Microdialysis-HPLC
    Kazunori Inaba, Toshiharu Oie, Hiroko Otake, Takeshi Kotake, Noriaki Nagai
    Chemical and Pharmaceutical Bulletin.2019; 67(2): 120.     CrossRef
  • Insomnia, Benzodiazepine Use, and Falls among Residents in Long-term Care Facilities
    Yu Jiang, Qinghua Xia, Jie Wang, Peng Zhou, Shuo Jiang, Vinod K. Diwan, Biao Xu
    International Journal of Environmental Research and Public Health.2019; 16(23): 4623.     CrossRef
  • Association Between Sleep Medications and Falls and Fall-related Worries in Community-Dwelling Older Adults in the United States
    Kathy Nguyen, Jonathan Watanabe
    Journal of Contemporary Pharmacy Practice.2019; 66(3): 23.     CrossRef
  • Z-drugs and risk for falls and fractures in older adults—a systematic review and meta-analysis
    Nir Treves, Amichai Perlman, Lital Kolenberg Geron, Angham Asaly, Ilan Matok
    Age and Ageing.2018; 47(2): 201.     CrossRef
  • Age, Sex, and Dose Effects of Nonbenzodiazepine Hypnotics on Hip Fracture in Nursing Home Residents
    David D. Dore, Andrew R. Zullo, Vincent Mor, Yoojin Lee, Sarah D. Berry
    Journal of the American Medical Directors Association.2018; 19(4): 328.     CrossRef
  • Cognitive Enhancers Associated with Decreased Risk of Injury in Patients with Dementia: A Nationwide Cohort Study in Taiwan
    Pei-Chun Chao, Wu-Chien Chien, Chi-Hsiang Chung, Ching-Wen Chu, Chin-Bin Yeh, San-Yuan Huang, Ru-Band Lu, Hsin-An Chang, Yu-Chen Kao, Hui-Wen Yeh, Wei-Shan Chiang, Yu-Ching Chou, Nian-Sheng Tzeng
    Journal of Investigative Medicine.2018; 66(3): 684.     CrossRef
  • Insomnia in Elderly Patients: Recommendations for Pharmacological Management
    Vivien C. Abad, Christian Guilleminault
    Drugs & Aging.2018; 35(9): 791.     CrossRef
  • Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications
    Shanna L. Burke, Tianyan Hu, Christine E. Spadola, Tan Li, Mitra Naseh, Aaron Burgess, Tamara Cadet
    Sleep Medicine.2018; 52: 168.     CrossRef
  • An effectiveness comparison of acupuncture treatments for insomnia disorder
    Jing Chen, Liming Lu, Nenggui Xu, Jun Chen, Yupeng Fan, Fen Feng, Xiaolan Qin, Yu Kui
    Medicine.2018; 97(35): e12060.     CrossRef
  • Zolpidem-Induced Acute Altered Level of Consciousness: A Report of Two Cases
    Abdolhamid Parsa, Seyyed Ali Tabaeian, Sadra Einizadeh, Mohammad Babaeian
    Iranian Journal of Psychiatry and Behavioral Sciences.2018;[Epub]     CrossRef
  • Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
    Daniel F. Kripke
    F1000Research.2018; 5: 918.     CrossRef
  • Effects of Ramelteon and Other Sleep-Promoting Drugs on Serum Low-Density Lipoprotein and Non-high-density Lipoprotein Cholesterol: A Retrospective Comparative Pilot Study
    Haruki Torii, Rumiko Shimizu, Yuriko Tanizaki, Yurina Omiya, Miwa Yamamoto, Sayaka Kamiike, Daisuke Yasuda, Yoshinori Hiraoka, Tohru Hashida, Noriaki Kume
    Biological and Pharmaceutical Bulletin.2018; 41(12): 1778.     CrossRef
  • Zopiclone Use and Risk of Fractures in Older People: Population-Based Study
    Prasad S. Nishtala, Te-yuan Chyou
    Journal of the American Medical Directors Association.2017; 18(4): 368.e1.     CrossRef
  • Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
    Daniel F. Kripke
    F1000Research.2017; 5: 918.     CrossRef
  • Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis
    Karen Donnelly, Robert Bracchi, Jonathan Hewitt, Philip A. Routledge, Ben Carter, Tuan Van Nguyen
    PLOS ONE.2017; 12(4): e0174730.     CrossRef
  • Benzodiazepines and Z-Drugs: An Updated Review of Major Adverse Outcomes Reported on in Epidemiologic Research
    Jaden Brandt, Christine Leong
    Drugs in R&D.2017; 17(4): 493.     CrossRef
  • Sleep in the Elderly
    Steven H. Feinsilver, Adam B. Hernandez
    Clinics in Geriatric Medicine.2017; 33(4): 579.     CrossRef
  • A Greater Extent of Insomnia Symptoms and Physician-Recommended Sleep Medication Use Predict Fall Risk in Community-Dwelling Older Adults
    Tuo-Yu Chen, Soomi Lee, Orfeu M Buxton
    Sleep.2017;[Epub]     CrossRef
  • High Prevalence of Inappropriate Benzodiazepine and Sedative Hypnotic Prescriptions among Hospitalized Older Adults
    Elisabeth Anna Pek, Andrew Remfry, Ciara Pendrith, Chris Fan‐Lun, R. Sacha Bhatia, Christine Soong
    Journal of Hospital Medicine.2017; 12(5): 310.     CrossRef
  • Zolpidem use and risk of fractures: a systematic review and meta-analysis
    S. M. Park, J. Ryu, D. R. Lee, D. Shin, J. M. Yun, J. Lee
    Osteoporosis International.2016; 27(10): 2935.     CrossRef
  • Melatonin, hypnotics and their association with fracture: a matched cohort study
    Martin Frisher, Nicholas Gibbons, James Bashford, Steve Chapman, Scott Weich
    Age and Ageing.2016; 45(6): 801.     CrossRef
  • Characteristics and Trends in Hypnotics Consumption in the Largest Health Care System in Israel
    O. Marom, G. Rennert, N. Stein, K. Landsman, G. Pillar
    Sleep Disorders.2016; 2016: 1.     CrossRef
  • Screening Tool for Older Persons’ Appropriate Prescriptions for Japanese: Report of the Japan Geriatrics Society Working Group on “Guidelines for medical treatment and its safety in the elderly”
    Taro Kojima, Katsuyoshi Mizukami, Naoki Tomita, Hiroyuki Arai, Takashi Ohrui, Masato Eto, Yasushi Takeya, Yoshitaka Isaka, Hiromi Rakugi, Noriko Sudo, Hidenori Arai, Hiroaki Aoki, Shigeo Horie, Shinya Ishii, Koh Iwasaki, Shin Takayama, Yusuke Suzuki, Tosh
    Geriatrics & Gerontology International.2016; 16(9): 983.     CrossRef
  • Review of Safety and Efficacy of Sleep Medicines in Older Adults
    Jennifer L. Schroeck, James Ford, Erin L. Conway, Kari E. Kurtzhalts, Megan E. Gee, Krista A. Vollmer, Kari A. Mergenhagen
    Clinical Therapeutics.2016; 38(11): 2340.     CrossRef
  • Nonbenzodiazepine Sedative Hypnotics and Risk of Fall-Related Injury
    Sarah E. Tom, Emerson M. Wickwire, Yujin Park, Jennifer S. Albrecht
    Sleep.2016; 39(5): 1009.     CrossRef
  • Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit
    Daniel F. Kripke
    F1000Research.2016; 5: 918.     CrossRef
  • Dependence, misuse, and beliefs regarding use of hypnotics by elderly psychiatric patients taking zolpidem, estazolam, or flunitrazepam
    Cheng-Fang Yen, Chih-Hung Ko, Yu-Ping Chang, Cheng-Ying Yu, Mei-Feng Huang, Yi-Chun Yeh, Jin-Jia Lin, Cheng-Sheng Chen
    Asia-Pacific Psychiatry.2015; 7(3): 298.     CrossRef
  • An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population
    Hsin-I Shih, Che-Chen Lin, Yi-Fang Tu, Chia-Ming Chang, Hsiang-Chin Hsu, Chih-Hsien Chi, Chia-Hung Kao
    Medicine.2015; 94(17): e809.     CrossRef
  • The Use of Hypnotics to Treat Sleep Problems in the Elderly
    Catherine McCall, John W. Winkelman
    Psychiatric Annals.2015;[Epub]     CrossRef
  • Risk of Type 2 Diabetes in Patients With Nonapnea Sleep Disorders in Using Different Types of Hypnotics
    Chia-Ling Lin, Mei-Chang Yeh, Tomor Harnod, Cheng-Li Lin, Chia-Hung Kao
    Medicine.2015; 94(38): e1621.     CrossRef
  • Care Needs and Clinical Outcomes of Older People with Dementia: A Population-Based Propensity Score-Matched Cohort Study
    Fei-Yuan Hsiao, Li-Ning Peng, Yu-Wen Wen, Chih-Kuang Liang, Pei-Ning Wang, Liang-Kung Chen, Alessandra Marengoni
    PLOS ONE.2015; 10(5): e0124973.     CrossRef
  • Is Zolpidem Associated with Increased Risk of Fractures in the Elderly with Sleep Disorders? A Nationwide Case Cross-Over Study in Taiwan
    Yih-Jing Tang, Shinn-Ying Ho, Fang-Ying Chu, Hung-An Chen, Yun-Ju Yin, Hua-Chin Lee, William Cheng-Chung Chu, Hui-Wen Yeh, Wei-Shan Chiang, Chia-Lun Yeh, Hui-Ling Huang, Nian-Sheng Tzeng, Uwe Rudolph
    PLOS ONE.2015; 10(12): e0146030.     CrossRef
  • Evaluation of risk factors for fractures in postmenopausal women with osteoporosis
    Viktória Ferencz, Csaba Horváth, Sándor Huszár, Katalin Bors
    Orvosi Hetilap.2015; 156(4): 146.     CrossRef
  • Association between use of benzodiazepines and risk of fractures: a meta-analysis
    D. Xing, X. L. Ma, J. X. Ma, J. Wang, Y. Yang, Y. Chen
    Osteoporosis International.2014; 25(1): 105.     CrossRef
  • Non-benzodiazepine hypnotics and older adults: what are we learning about zolpidem?
    Hedva B Levy
    Expert Review of Clinical Pharmacology.2014; 7(1): 5.     CrossRef
  • Long-Term Use of Zolpidem Increases the Risk of Major Injury: A Population-Based Cohort Study
    Ming-May Lai, Cheng-Chieh Lin, Che-Chen Lin, Chiu-Shong Liu, Tsai-Chung Li, Chia-Hung Kao
    Mayo Clinic Proceedings.2014; 89(5): 589.     CrossRef
  • Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study
    Marit Stordal Bakken, Anders Engeland, Lars B. Engesæter, Anette Hylen Ranhoff, Steinar Hunskaar, Sabine Ruths
    European Journal of Clinical Pharmacology.2014; 70(7): 873.     CrossRef
  • Treatment of Insomnia in Older Adults: Re-Evaluating the Benefits and Risks of Sedative Hypnotic Agents
    Nicole J. Brandt, Jennifer M. Piechocki
    Journal of Gerontological Nursing.2013; 39(4): 48.     CrossRef
  • In the Zzz Zone: The Effects of Z-Drugs on Human Performance and Driving
    Naren Gunja
    Journal of Medical Toxicology.2013; 9(2): 163.     CrossRef
  • Ten-year trend in prescriptions of z-hypnotics among the elderly: A nationwide, cross-sectional study in Taiwan
    Fei-Yuan Hsiao, Pei-Hua Hsieh, Churn-Shiouh Gau
    Journal of Clinical Gerontology and Geriatrics.2013; 4(2): 37.     CrossRef
  • Zolpidem, Is it a Safe Drug for Insomnia Management?
    Kyung Hee Park, Jae-Hyun Lee
    Korean Journal of Medicine.2013; 84(6): 802.     CrossRef
English Abstracts
The Risk of Fracture with Taking Alpha Blockers for Treating Benign Prostatic Hyperplasia.
Joongyub Lee, Nam Kyoung Choi, Sun Young Jung, Ye Jee Kim, Jong Mi Seong, Seung June Oh, Byung Joo Park
J Prev Med Public Health. 2009;42(3):165-170.
DOI: https://doi.org/10.3961/jpmph.2009.42.3.165
  • 5,306 View
  • 62 Download
  • 6 Crossref
AbstractAbstract PDF
OBJECTIVES
We evaluated the risk of fracture associated with hypotension-related adverse drug reaction caused by taking alpha blockers to treat benign prostatic hyperplasia (BPH). METHODS: We used the Health Insurance Review and Assessment Service database from January 1st 2005 to June 30th 2006 for this study. The male patients with BPH and who had a prescription for alpha blockers following any fractures were defined as the cases. We set the 20 day long hazard period prior to the index date and the four control periods whose lengths were same with hazard period. After 1:4 matching of the hazard and control periods, conditional logistic regression was used to calculate the odds ratios for the risk of fractures as related to the alpha blocker exposure. RESULTS: Doxazosin and tamsulosin showed the increased risk of fractures, whereas terazosin did not. After stratification using the defined daily doses, a protective effect was shown for the patients who took terazosin at the doses lower than 0.4 DDD and the hazardous effect at the doses higher than or equal to 0.4 DDD. There was no significant difference for the risk of patients taking tamsulosin at the doses higher than 1.0 DDD but there was a statistically significant increase in the risk at the doses higher than or equal to 1.0 DDD. CONCLUSIONS: Alpha blockers for BPH may increase the risk of fracture in elderly patients who have comorbidities and take the concomitant medications. Alpha blockers need to be prescribed with caution, although some have high prostate specificity.
Summary

Citations

Citations to this article as recorded by  
  • Risk for Hip Fracture due to Alpha Blocker Treatment in Korean Women: National Health Insurance Database Study
    Gi H. SEO, Sung R. SHIM, Hwan W. LEE, Jin H. KIM, Dong‐Il CHUN, Hyun J. KIM, Hyun Y. LEE, Jae H. KIM
    LUTS: Lower Urinary Tract Symptoms.2018; 10(2): 175.     CrossRef
  • Risk of hip/femur fractures during the initiation period of α‐adrenoceptor blocker therapy among elderly males: a self‐controlled case series study
    Chao‐Lun Lai, Raymond Nien‐Chen Kuo, Ho‐Min Chen, Ming‐Fong Chen, Kinwei Arnold Chan, Mei‐Shu Lai
    British Journal of Clinical Pharmacology.2015; 80(5): 1208.     CrossRef
  • The Association of Alpha-Blockers and 5-Alpha Reductase Inhibitors in Benign Prostatic Hyperplasia With Fractures
    Sian Yik Lim, Pavis Laengvejkal, Ragesh Panikkath, Kenneth Nugent
    The American Journal of the Medical Sciences.2014; 347(6): 463.     CrossRef
  • Alpha-adrenergic blocker mediated osteoblastic stem cell differentiation
    Yoon Jung Choi, Jue Yeon Lee, Seung Jin Lee, Chong-Pyoung Chung, Yoon Jeong Park
    Biochemical and Biophysical Research Communications.2011; 416(3-4): 232.     CrossRef
  • Risk of fractures associated with treatment for benign prostate hyperplasia in men
    P. Vestergaard, L. Rejnmark, L. Mosekilde
    Osteoporosis International.2011; 22(2): 731.     CrossRef
  • Databases in Asia and Record-Linkage
    Kiyoshi KUBOTA
    Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku.2011; 16(1): 27.     CrossRef
Estimating the Economic Burden of Osteoporotic Vertebral Fracture among Elderly Korean Women.
Hye Young Kang, Dae Ryong Kang, Young Hwa Jang, Sung Eun Park, Won Jung Choi, Seong Hwan Moon, Kyu Hyun Yang
J Prev Med Public Health. 2008;41(5):287-294.
DOI: https://doi.org/10.3961/jpmph.2008.41.5.287
  • 5,468 View
  • 86 Download
  • 13 Crossref
AbstractAbstract PDF
OBJECTIVES
To estimate the economic burden of osteoporotic vertebral fracture (VF) from a societal perspective. METHODS: From 2002 to 2004, we identified all National Health Insurance claims records for women > or = 50 years old with a diagnosis of VF. The first 6-months was defined as a "clearance period," Ysuch that patients were considered as incident cases if their first claim of fracture was recorded after June 30, 2002. We only included patients with > or = one claim of a diagnosis of, or prescription for, osteoporosis over 3 years. For each patient, we cumulated the claims amount for the first visit and for the follow-up treatments for 1 year. The hospital charge data from 4 hospitals were investigated to measure the proportion of the non-covered services. Face-to-face interviews were conducted with 106 patients from the 4 study sites to measure the out-of-pocket spending outside of hospitals. RESULTS: During 2.5 years, 131,453 VF patients were identified. The patients had an average of 3.38 visits, 0.40 admissions and 6.36 inpatient days. The per capita cost was 1,909,690 Won: 71.5% for direct medical costs, 20.6% for direct non-medical costs and 7.9% for indirect costs. The per capita cost increased with increasing age: 1,848,078 Won for those aged 50-64, 2,084,846 Won for 65-74, 2,129,530 Won for 75-84and 2,121,492 Won for those above 84. CONCLUSIONS: Exploring the economic burden of osteoporotic VF is expected to motivate to adopt effective treatment options for osteoporosis in order to prevent the incidence of fracture and the consequent costs.
Summary

Citations

Citations to this article as recorded by  
  • A Study of Prevalence and Awareness of Low Bone Density of Female Utilizing Dental Panoramic Radiographs
    Sung Jin Kim, In-Ja Song, Eun Joo Lee, Suk-Ja Yoon
    The Korean Journal of Oral and Maxillofacial Pathology.2024; 48(3): 23.     CrossRef
  • A Review of Domestic and International Clinical Research Trends on Pharmacopuncture Treatment for Fractures
    Hea Sun Chun
    Journal of Physiology & Pathology in Korean Medicine.2023; 37(6): 185.     CrossRef
  • Absolute Bed Rest Duration of 3 Days for Osteoporotic Vertebral Fractures: A Retrospective Study
    Sung Tan Cho, Seung Joo Kim, Bum Joon Nam, Kun Woo Kim, Gyu Hyeon Lee, Jin Hwan Kim
    Asian Spine Journal.2022; 16(6): 898.     CrossRef
  • Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in South Korea: a simulation projection model from 2020 to 2040
    Micah Jackson, Kyu Hyun Yang, Matthew Gitlin, Zachary Wessler
    Archives of Osteoporosis.2021;[Epub]     CrossRef
  • Healthcare Resource Utilization and Direct Medical Costs for Patients With Osteoporotic Fractures in China
    Jing Wu, Yi Qu, Ke Wang, Yu Chen
    Value in Health Regional Issues.2019; 18: 106.     CrossRef
  • A meta-analysis of breastfeeding and osteoporotic fracture risk in the females
    X. Duan, J. Wang, X. Jiang
    Osteoporosis International.2017; 28(2): 495.     CrossRef
  • Economic Burden of Osteoporotic Fracture of the Elderly in South Korea: A National Survey
    Jinhyun Kim, Eunhee Lee, Sungjae Kim, Tae Jin Lee
    Value in Health Regional Issues.2016; 9: 36.     CrossRef
  • Lifestyle and Genetic Predictors of Stiffness Index in Community-dwelling Elderly Korean Men and Women
    Kyung-Ae Park, Yeon-Hwan Park, Min-Hee Suh, Smi Choi-Kwon
    Asian Nursing Research.2015; 9(3): 251.     CrossRef
  • The Epidemiology and Importance of Osteoporotic Spinal Compression Fracture in South Korea
    Hun-Kyu Shin, Jong-Hyon Park
    Journal of Korean Society of Spine Surgery.2015; 22(3): 99.     CrossRef
  • The Socioeconomic Burden of Coronary Heart Disease in Korea
    Hoo-Sun Chang, Han-Joong Kim, Chung-Mo Nam, Seung-Ji Lim, Young-Hwa Jang, Sera Kim, Hye-Young Kang
    Journal of Preventive Medicine and Public Health.2012; 45(5): 291.     CrossRef
  • Epidemiology and Economic Burden of Osteoporosis in South Korea
    Yong-Chan Ha
    Journal of the Korean Fracture Society.2011; 24(1): 114.     CrossRef
  • How Much Amount of Socioeconomic Loss Is Caused by Digestive Diseases?
    Kyung Sik Park
    The Korean Journal of Gastroenterology.2011; 58(6): 297.     CrossRef
  • Study of the Level of Osteoporosis Awareness among Women Dwelling in Urban Area
    Miyoung Chung, Kyunghye Hwang, Euysoon Choi
    Korean Journal of Women Health Nursing.2009; 15(4): 362.     CrossRef
Effects of Long-term Fluoride in Drinking Water on Risks of Hip Fracture of the Elderly: An Ecologic Study Based on Database of Hospitalization Episodes.
Eun Young Park, Seung Sik Hwang, Jai Yong Kim, Soo Hun Cho
J Prev Med Public Health. 2008;41(3):147-152.
DOI: https://doi.org/10.3961/jpmph.2008.41.3.147
  • 5,109 View
  • 63 Download
  • 4 Crossref
AbstractAbstract PDF
OBJECTIVES
Fluoridation of drinking water is known to decrease dental caries, particularly in children. However, the effects of fluoridated water on bone over several decades are still in controversy. To assess the risk of hip fracture related to water fluoridation, we evaluated the hip fracture-related hospitalizations of the elderly between a fluoridated city and non-fluoridated cities in Korea. METHODS: Cheongju as a fluoridated area and Chungju, Chuncheon, Suwon, Wonju as non-fluoridated areas were chosen for the study. We established a database of hip fracture hospitalization episode based on the claims data submitted to the Health Insurance Review Agency from January 1995 to December 2002. The hip fracture hospitalization episodes that satisfied the conditions were those that occurred in patients over 65 years old, the injuries had a hip fracture code (ICD-9 820, ICD-10 S72) and the patients were hospitalized for at least 7days. A total of 80,558 cases of hip fracture hospitalization episodes were analyzed. RESULTS: The admission rates for hip fracture increased with the age of the men and women in both a fluoridated city and the non-fluoridated cities (p<0.01). The relative risk of hip fracture increased significantly both for men and women as their age increased. However, any difference in the hip fracture admission rates was not consistently observed between the fluoridated city and the nonfluoridated cities. CONCLUSIONS: We cannot conclude that fluoridation of drinking water increases the risk of hip fracture in the elderly.
Summary

Citations

Citations to this article as recorded by  
  • The Association between Community Water Fluoridation and Bone Diseases: A Natural Experiment in Cheongju, Korea
    Naae Lee, Sungchan Kang, Woojoo Lee, Seung-sik Hwang
    International Journal of Environmental Research and Public Health.2020; 17(24): 9170.     CrossRef
  • Community water fluoridation and health outcomes in England: a cross‐sectional study
    Nicholas Young, John Newton, John Morris, Joan Morris, John Langford, Jonathan Iloya, Diane Edwards, Semina Makhani, Julia Verne
    Community Dentistry and Oral Epidemiology.2015; 43(6): 550.     CrossRef
  • Exposure to Fluoride in Drinking Water and Hip Fracture Risk: A Meta-Analysis of Observational Studies
    Xin-Hai Yin, Guang-Lei Huang, Du-Ren Lin, Cheng-Cheng Wan, Ya-Dong Wang, Ju-Kun Song, Ping Xu, Yi-Hsiang Hsu
    PLOS ONE.2015; 10(5): e0126488.     CrossRef
  • Effects of Life-long Fluoride Intake on Bone Measures of Adolescents
    S.M. Levy, J.J. Warren, K. Phipps, E. Letuchy, B. Broffitt, J. Eichenberger-Gilmore, T.L. Burns, G. Kavand, K.F. Janz, J.C. Torner, C.A. Pauley
    Journal of Dental Research.2014; 93(4): 353.     CrossRef
Original Articles
Physical Activity and Hip Fracture in Elderly People: A Cohort Study in Korea.
Kyung Eun Youn, Seung Mi Lee, Yooni Kim, Byung Joo Park
Korean J Prev Med. 2002;35(4):351-358.
  • 2,509 View
  • 27 Download
AbstractAbstract PDF
OBJECTIVE
To evaluate the relationship between physical activity and the risk of hip fracture in the elderly Korean people. METHODS: The study population was a Physical Activity Subcohort (n=8,908) extracted from the Korean Elderly Pharmacoepidemiological Cohort (KEPEC). Physical activity information was obtained from a mailed questionnaire surveys. The outcome data was collected from claims data gathered between Jan. 1993 and Dec. 1998. A hospital survey relating to potential cases was conducted to confirm the final diagnoses. The abstracted data was reviewed by a medical doctor before the final diagnoses were confirmed. A mailing questionnaire survey was performed to obtain information on potentially confounding variables, including alcohol intake, smoking habits, weight, height and postmenopausal duration. There were 79 confirmed cases hospitalized due to hip fractures between Jan. 1993 and Dec. 1998. Relative risk of physical activity scores on the hip fracture, and their 95% confidence intervals, were estimated by a Cox's proportional hazard model using SAS for Windows ver. 6.12. RESUJLTS: Compared to the reference group, the adjusted relative risk of hip fracture associated with the most physical active category; after controlling for age, weight and alcohol intake in the males, and for weight, alcohol intake and postmenopausal duration in the females, were 1.04 (95% CI=0.35-3.06) and 0.44 (95% CI=0.26-0.77), respectively. CONCLUSIONS: Physical activity may protect elderly women from hip fracture.
Summary
Reproductive History and Hip Fracture in the Elderly Women in Korea: A Cohort Study.
Seung Mi Lee, Yooni Kim, Koung Eun Youn, Byung Joo Park
Korean J Prev Med. 2002;35(4):305-312.
  • 2,605 View
  • 25 Download
AbstractAbstract PDF
OBJECTIVES
The reproductive history of women has been suggested to have a possible influence on the risk of osteoporotic fractures. The purpose of this study was to assess the association between reproductive history and hip fractures in the elderly women. METHODS: The study subjects were drawn from women members of the Korean Elderly Pharmacoepidemiologic Cohort (KEPEC), aged 65 years or over, whose reproductive histories were available, and who were beneficiaries of the Korea Medical Insurance Corporation (KMIC) in 1993 and lived in Busan city, Korea. The information on reproductive histories, and possible confounders, were collected from mailed questionnaires. Potential hip fracture cases were collected from the claims data obtained between 1993 and 1998, with a hospital survey conducted to confirm the final diagnoses. Rate ratios and their 95% confidence intervals, were calculated using a Cox's proportional hazard model. RESUJLTS: Following up 5,219 women for 6 years, 51 cases were confirmed with hip fractures. When adjusted for age, weight and physical activity, the rate ratio of hip fractures in women who had given birth three or more times was 0.56 (95% CI: 0.25 - 1.25), compared with those who had given birth two or less times. When adjusted for age, number of births, weight and physical activity, the rate ratio in women who first gave birth when younger than 22 years was 0.60 (95% CI: 0.34 - 1.08) compared with those who had giving birth at 22 years or older. CONCLUSIONS: According to these findings, an early age when first giving birth might decrease the risk of hip fractures in elderly Korean women.
Summary

JPMPH : Journal of Preventive Medicine and Public Health
TOP